7.4 million
Estimated Americans age 65+ living with Alzheimer’s dementia in 2026. Alzheimer’s Association.
FOR INVESTORS
InXite is building an intelligence platform that connects people, evidence and services around the decisions that shape their lives—starting with brain health.
THE OPPORTUNITY
Complex health decisions bring fragmented information, uncertain costs and disconnected services. These figures show the scale of the health need; they are not estimates of InXite revenue or addressable customers.
Estimated Americans age 65+ living with Alzheimer’s dementia in 2026. Alzheimer’s Association.
Approximately this many TBI-related U.S. hospitalizations occurred in 2020. Hospitalizations are events, not a count of unique potential members. CDC.
U.S. adults experienced any mental illness in the past year in 2024, or 23.4% of adults. SAMHSA.
Populations may overlap. Measures and reporting years differ and should not be added together.
STRATEGY
InXite Enterprise Outcome Intelligence™ connects enterprise context, alternative-path modeling, evidence-based recommendations, authorized decisions, execution, and observed outcomes into a continuously improving decision system.
Begin with veteran TBI needs, where care, recovery, behavioral health and daily life intersect. Use a focused launch to refine the experience before expanding.
Bring longitudinal context into the next decision: compare possible paths, identify missing evidence, update recommendations as information changes and learn from observed outcomes.
Combine LOLA, personal health context, cost comparisons and partner navigation so members can understand choices and act with appropriate authorization.
Develop sponsor and partner relationships that can support access across populations while preserving member choice and program-specific governance.
INTELLECTUAL PROPERTY
The technology strategy spans five related subject areas. This overview describes the work; it makes no representation about patent filing, grant or pending status.
Use the timing, relevance and provenance of evidence to inform journey updates and the next decision.
Represent a person’s priorities and trade-offs when comparing possible paths.
Model the cost and financial implications of alternatives alongside the health journey.
Represent evolving pathways and identify where observed progress diverges from expectations.
Maintain consistent comparison baselines and distinguish evidence-backed findings from claims requiring further validation.
GO-TO-MARKET
This is the intended rollout approach. Sponsor partnerships can develop across phases; this is not a claim of signed contracts, guaranteed enrollment or completed launches.
BUSINESS MODEL
Planned membership access to decision support, navigation and personal journey tools. Packaging and pricing will be defined by offering.
Program agreements with self-insured employers, Health Share Ministries, associations, health plans and other organizations supporting access for their members or populations, with agreed implementation and reporting scope.
Service and integration relationships that connect qualified offerings to relevant journeys. Commercial terms and participation will be defined by agreement.
LEADERSHIP
James Paat is the founder and CEO of InXite Data Systems LLC. His work brings together healthcare technology, enterprise intelligence, product strategy and commercialization. He leads InXite’s development of a shared intelligence foundation and its application to consumer healthcare decisions, brain health journeys and enterprise outcomes.
INVESTOR FAQ
InXite Data provides the shared technology foundation. InXite IHX applies that foundation to healthcare, with IHX Brain Health as a specialized solution. InXite Global presents the broader enterprise story and IGX applications.
Request an investor overview and a conversation about the platform, commercialization plans, business model and diligence materials available for review. Requests are reviewed by the team; submission does not automatically deliver documents.
Demonstrations illustrate the intended experience. Availability, integrations, partner participation and program scope must be confirmed for each deployment.
No. This page is for informational purposes only and is not an offer to sell or a solicitation to buy securities. Any potential transaction would require separate documentation and applicable review.
START A CONVERSATION
Tell us who you are and what you would like to explore. The InXite team will follow up about appropriate materials and next steps.
This page is for informational purposes only. It is not an offer to sell or a solicitation to purchase securities. No returns, financing outcome or investment availability are promised.